Patents by Inventor Lawrence A. Trissel

Lawrence A. Trissel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9289408
    Abstract: Stable aqueous solutions comprising concentrations of baclofen in the range of greater than 2.0 mg/mL up to about 10 mg/mL are disclosed. These solutions can be used as pharmaceuticals for parenteral or oral administration. The invention also provides methods of preparing said stable aqueous baclofen solutions.
    Type: Grant
    Filed: August 7, 2013
    Date of Patent: March 22, 2016
    Assignee: Board of Regents, The University of Texas System
    Inventors: Lawrence A. Trissel, Yanping Zhang
  • Publication number: 20130331451
    Abstract: Stable aqueous solutions comprising concentrations of baclofen in the range of greater than 2.0 mg/mL up to about 10 mg/mL are disclosed. These solutions can be used as pharmaceuticals for parenteral or oral administration. The invention also provides methods of preparing said stable aqueous baclofen solutions.
    Type: Application
    Filed: August 7, 2013
    Publication date: December 12, 2013
    Applicant: Board of Regents, The University of Texas System
    Inventors: Lawrence A. Trissel, Yanping Zhang
  • Patent number: 8529916
    Abstract: Stable aqueous solutions comprising concentrations of baclofen in the range of greater than 2.0 mg/mL up to about 10 mg/mL are disclosed. These solutions can be used as pharmaceuticals for parenteral or oral administration. The invention also provides methods of preparing said stable aqueous baclofen solutions.
    Type: Grant
    Filed: January 16, 2013
    Date of Patent: September 10, 2013
    Assignee: Board of Regents The University of Texas System
    Inventors: Lawrence A. Trissel, Yanping Zhang
  • Publication number: 20130131176
    Abstract: Stable aqueous solutions comprising concentrations of baclofen in the range of greater than 2.0 mg/mL up to about 10 mg/mL are disclosed. These solutions can be used as pharmaceuticals for parenteral or oral administration. The invention also provides methods of preparing said stable aqueous baclofen solutions.
    Type: Application
    Filed: January 16, 2013
    Publication date: May 23, 2013
    Applicant: Board of Regents, The University of Texas System
    Inventors: Lawrence A. Trissel, Yanping Zhang
  • Patent number: 8357379
    Abstract: Stable aqueous solutions comprising concentrations of baclofen in the range of greater than 2.0 mg/mL up to about 10 mg/mL are disclosed. These solutions can be used as pharmaceuticals for parenteral or oral administration. The invention also provides methods of preparing said stable aqueous baclofen solutions.
    Type: Grant
    Filed: November 18, 2011
    Date of Patent: January 22, 2013
    Assignee: Board of Regents, The University of Texas System
    Inventors: Lawrence A. Trissel, Yanping Zhang
  • Publication number: 20120065268
    Abstract: Stable aqueous solutions comprising concentrations of baclofen in the range of greater than 2.0 mg/mL up to about 10 mg/mL are disclosed. These solutions can be used as pharmaceuticals for parenteral or oral administration. The invention also provides methods of preparing said stable aqueous baclofen solutions.
    Type: Application
    Filed: November 18, 2011
    Publication date: March 15, 2012
    Inventors: Lawrence A. Trissel, Yanping Zhang
  • Patent number: 8062647
    Abstract: Stable aqueous solutions comprising concentrations of baclofen in the range of greater than 2.0 mg/mL up to about 10 mg/mL are disclosed. These solutions can be used as pharmaceuticals for parenteral or oral administration. The invention also provides methods of preparing said stable aqueous baclofen solutions.
    Type: Grant
    Filed: September 28, 2010
    Date of Patent: November 22, 2011
    Assignee: Board of Regents, The University of Texas System
    Inventors: Lawrence A. Trissel, Yanping Zhang
  • Publication number: 20110105614
    Abstract: Stable aqueous solutions comprising concentrations of baclofen in the range of greater than 2.0 mg/mL up to about 10 mg/mL are disclosed. These solutions can be used as pharmaceuticals for parenteral or oral administration. The invention also provides methods of preparing said stable aqueous baclofen solutions.
    Type: Application
    Filed: September 28, 2010
    Publication date: May 5, 2011
    Inventors: Lawrence A. Trissel, Yanping Zhang
  • Patent number: 7824697
    Abstract: Stable aqueous solutions comprising concentrations of baclofen in the range of greater than 2.0 mg/mL up to about 10 mg/mL are disclosed. These solutions can be used as pharmaceuticals for parenteral or oral administration. The invention also provides methods of preparing said stable aqueous baclofen solutions.
    Type: Grant
    Filed: June 17, 2005
    Date of Patent: November 2, 2010
    Assignee: Board of Regents, The University of Texas System
    Inventors: Lawrence A. Trissel, Yanping Zhang
  • Publication number: 20060009523
    Abstract: Stable aqueous solutions comprising concentrations of baclofen in the range of greater than 2.0 mg/mL up to about 10 mg/mL are disclosed. These solutions can be used as pharmaceuticals for parenteral or oral administration. The invention also provides methods of preparing said stable aqueous baclofen solutions.
    Type: Application
    Filed: June 17, 2005
    Publication date: January 12, 2006
    Inventors: Lawrence Trissel, Yanping Zhang
  • Patent number: 5801188
    Abstract: This invention provides methods for intraspinal administration of therapeutically-effective amounts of clonidine for alleviating acute and chronic pain.
    Type: Grant
    Filed: January 8, 1997
    Date of Patent: September 1, 1998
    Assignee: Medtronic Inc.
    Inventors: Samuel J. Hassenbusch, III, Patrick Edeburn, Lawrence A. Trissel
  • Patent number: 5681846
    Abstract: The present invention is directed to improved pharmaceutical compositions employing paclitaxel that are formulated to increase stability and solubility. These improved formulations are useful in long-term, multi-day continuous infusion protocols, and have the advantage of reducing the number of infusion system breaks during the entire period of drug administration. Also disclosed are kits for use in preparing paclitaxel for long-term infusion and enhanced solubility.
    Type: Grant
    Filed: March 17, 1995
    Date of Patent: October 28, 1997
    Assignee: Board of Regents, The University of Texas System
    Inventor: Lawrence A. Trissel